| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 8 |
| 1 | PREDNISOLONE ORAL | 8 |
| 2 | PREDNISOLONE ORAL SOLUTION | 8 |
| 3 | CYCLOSPORINE | 5 |
| 4 | AMPHOTERICIN B | 4 |
| 5 | CARBOPLATIN | 4 |
| 6 | DACTINOMYCIN | 4 |
| 7 | ETOPOSIDE | 4 |
| 8 | FUROSEMIDE | 4 |
| 9 | IFOSFAMIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 4 | 0.0018 |
| 1 | FLUCYTOSINE | 2 | 0.0014 |
| 2 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 3 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 4 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 5 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 6 | TREOSULFAN | 1 | 0.0004 |
| 7 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 8 | AMPHOTERICIN B | 4 | 0.0003 |
| 9 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 15 |
| 1 | Alkylating Drug [EPC] | 6 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 5 |
| 3 | Platinum-based Drug [EPC] | 5 |
| 4 | Actinomycin [EPC] | 4 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 4 |
| 6 | Loop Diuretic [EPC] | 4 |
| 7 | Polyene Antifungal [EPC] | 4 |
| 8 | Topoisomerase Inhibitor [EPC] | 4 |
| 9 | Azole Antifungal [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 4 | 0.0018 |
| 1 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 3 | Polyene Antifungal [EPC] | 4 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |